| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/20/2000 | EP1035780A1 Method for purifying heat shock peptides complexes |
| 09/20/2000 | EP1011705A4 Conjugates targeted to the interleukin-2 receptor |
| 09/20/2000 | EP0934072A4 Manufacturing process for the production of purified transferrin |
| 09/20/2000 | EP0854883A4 Developmentally-regulated endothelial cell locus-1 |
| 09/20/2000 | EP0832119B1 Anti-fungal and anti-bacterial histatin-based peptides |
| 09/20/2000 | EP0792291B1 Protein affecting katp channels |
| 09/20/2000 | EP0766735B1 Class bi and ci scavenger receptors |
| 09/20/2000 | EP0764030B1 Composition containing autoantibodies for tumor therapy and prophylaxis |
| 09/20/2000 | EP0742834B1 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
| 09/20/2000 | EP0672057B1 Analogs of pth |
| 09/20/2000 | EP0623216B1 IMMUNOCHEMICAL DETECTION OF $i(IN VIVO) ADVANCED GLYCOSYLATION ENDPRODUCTS |
| 09/20/2000 | EP0586549B1 Selecting ligand agonists and antagonists |
| 09/20/2000 | EP0579765B1 Method and composition for the treatment of herpes related disorders |
| 09/20/2000 | EP0504327B1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 09/20/2000 | CN1267331A Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes |
| 09/20/2000 | CN1267307A Interleukin-18 binding proteins, their preparation and use |
| 09/20/2000 | CN1267306A Cyclopeptide derivs. as adhesion inhibitors |
| 09/20/2000 | CN1267225A Method for treatment of patients afflicted with multiple sclerosis using consensus interferon |
| 09/20/2000 | CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b |
| 09/20/2000 | CN1267223A Carcinostatic agents |
| 09/20/2000 | CN1056619C Peptide haivng activity as inhibitors of platelet aggregation, pharmaceutical composition contg. same and use thereof |
| 09/20/2000 | CN1056618C Acylated insulin and pharmaceutical composition contg. same |
| 09/20/2000 | CN1056617C Melanoma-inhibiting protein |
| 09/20/2000 | CN1056615C Difluoro pentapeptide deriv. antiinflammatory agent |
| 09/20/2000 | CN1056608C Pseudodipeptide product having imidazole group and applications |
| 09/20/2000 | CN1056537C Pharmaceutical formulation |
| 09/19/2000 | US6121435 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 09/19/2000 | US6121434 An oligonucleotide diagnostic agent; for the diagnosis and treatment of cancer, restenosis, a nd viral diseases affected by intergrins |
| 09/19/2000 | US6121426 Fibrin binding domain polypeptides and uses and methods of producing same |
| 09/19/2000 | US6121417 Inhibitors of retroviral protease |
| 09/19/2000 | US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders |
| 09/19/2000 | US6121415 An epidermal growth factor receptor polypeptide; for the treatment of nervous system disorders and nervous system damage |
| 09/19/2000 | US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides |
| 09/19/2000 | US6121325 Naphthyl compounds promote release of growth hormone |
| 09/19/2000 | US6121247 Locally administering to patient preparation comprising dna expression construct comprising human gamma-interferon coding sequence |
| 09/19/2000 | US6121246 Method for treating ischemic tissue |
| 09/19/2000 | US6121240 Urokinase receptor ligands |
| 09/19/2000 | US6121238 Peptides and compounds that bind to a receptor |
| 09/19/2000 | US6121237 Administering peptide derived from primary amino acid sequence of human tumor necrosis factor to treat depressed neutrophil, macrophage or monocyte function |
| 09/19/2000 | US6121236 Multivalent ligands which modulate angiogenesis |
| 09/19/2000 | US6121235 Treatment of balance impairments |
| 09/19/2000 | US6121234 Use of essential oils to increase bioavailability of orally administered pharmaceutical compounds |
| 09/19/2000 | US6121233 Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules |
| 09/19/2000 | US6121232 Stabilized mixture comprising fibrinogen |
| 09/19/2000 | US6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury |
| 09/19/2000 | US6121230 Administering polypeptide acting as vascular endothelial growth factor antagonist to treat and/or prevent endometriosis |
| 09/19/2000 | US6121057 Methods of detecting antibodies to α-Fodrin and fragments thereof in diagnosing sjogrens' |
| 09/19/2000 | US6121047 Antisense modulation of SHP-1 expression |
| 09/19/2000 | US6121046 Synthetic antisense oligodeoxynucleotides targeted to human ache |
| 09/19/2000 | US6121045 Nucleotide and amino acid sequences; involved in modulating the growth and/or differentiation of endothelial cells; treatment and diagnosis of nervous system and vascular system disorders; alzheimer's/parkinson's diseases |
| 09/19/2000 | US6121037 Nucleic acid which encodes protein having defined amino acid sequence; for diagnostic reagents against neisseria species infections such as gonorrhea and meningitis; vaccines |
| 09/19/2000 | US6121036 Purified, host-specific, nontoxic, wide host range, virulent preparation against staphylococcus, helicobacter, mycobacterium, streptococcus, klebsiella, enterobacter, proteus, bacteriodes, pseudomonas, escherichia and others |
| 09/19/2000 | US6121028 MurE |
| 09/19/2000 | US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents |
| 09/19/2000 | US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases |
| 09/19/2000 | US6121017 Nucleotide and amino acid sequences; for diagnostic evaluation and prognosis of various disorders |
| 09/19/2000 | US6121016 DNA encoding human follicle stimulating hormone receptor, vectors and cells containing such DNA, and methods of use thereof |
| 09/19/2000 | US6121005 Human growth arrest specific homeobox protein; transcription factor; for treatment of postangioplasty restenosis and other cardiovascular disorders; for screening cellular partners |
| 09/19/2000 | US6120988 Method of detecting hev infection |
| 09/19/2000 | US6120807 Prolonged release of GM-CSF |
| 09/19/2000 | US6120794 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 09/19/2000 | US6120787 Sustained release particles |
| 09/19/2000 | US6120777 High fluorescence specific immune enhancing factor and methods of use for same |
| 09/19/2000 | US6120771 Isolated polypeptide; diagnosis, therapy |
| 09/19/2000 | US6120769 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| 09/19/2000 | US6120767 Genetic engineering |
| 09/19/2000 | US6120766 CDW52-specific antibody for treatment of multiple sclerosis |
| 09/19/2000 | US6120765 Purified peptide |
| 09/19/2000 | US6120763 Compositions and methods for enhanced tumor cell immunity in vivo |
| 09/19/2000 | US6120762 Genetic engineering |
| 09/19/2000 | US6120761 Mixture containing histidine stabilizer |
| 09/19/2000 | US6120760 Isolated protein; hybrid; bone disorders |
| 09/19/2000 | US6120491 Selective removal of benzyl esters to form pendent carboxylic acid groups by palladium-catalyzed hydrogenolysis from poly-arylates and polycarbonates in a tertiary-amide solvent; kinetics; surgical barriers; implant coatings; drug delivery |
| 09/19/2000 | CA2273834A1 Immunomodulator, immunomodulator food and immunomodulator feed |
| 09/19/2000 | CA2141679C New derivatives of neuraminic acid |
| 09/19/2000 | CA2106768C Bradykinin type peptides |
| 09/19/2000 | CA2079187C Cyclohexapeptidyl bisamine compounds |
| 09/19/2000 | CA2071538C Hpth (1-37) fragment, its production, drug containing it and its use |
| 09/19/2000 | CA2053242C Protease inhibitor |
| 09/19/2000 | CA2050601C Production in bacteria and yeast of hemoglobin and analogues thereof |
| 09/14/2000 | WO2000053808A1 Beclin and uses thereof |
| 09/14/2000 | WO2000053793A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 09/14/2000 | WO2000053776A2 Human kallikrein-like genes |
| 09/14/2000 | WO2000053774A2 Metalloproteinases and methods of use therefor |
| 09/14/2000 | WO2000053773A2 Methods for mitochondrial gene therapy |
| 09/14/2000 | WO2000053770A1 cDNA MOLECULES OF THE MEMBERS OF GENE FAMILY ENCODING HUMAN FATTY ACID DESATURASES AND THEIR USE IN DIAGNOSIS AND THERAPY |
| 09/14/2000 | WO2000053761A2 Human cytokine as ligand of the zalpha receptor and uses thereof |
| 09/14/2000 | WO2000053758A2 Compositions and methods for the treatment of immune related diseases |
| 09/14/2000 | WO2000053757A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/14/2000 | WO2000053756A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/14/2000 | WO2000053755A2 Compositions and methods for the treatment of tumor |
| 09/14/2000 | WO2000053753A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/14/2000 | WO2000053752A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/14/2000 | WO2000053751A1 Methods and compositions for inhibiting neoplastic cell growth |
| 09/14/2000 | WO2000053750A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | WO2000053748A2 Casb618 polynucleotides and polypeptides and their use |
| 09/14/2000 | WO2000053747A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) |
| 09/14/2000 | WO2000053742A2 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | WO2000053738A2 Methods and compositions for regulating memory consolidation |
| 09/14/2000 | WO2000053735A2 Methods for identifying modulators of synaptic plasticity and cell motility |